The latest update of “Global Pulmonary Arterial Hypertension Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Pulmonary Arterial Hypertension Market.
Overview of the Pulmonary Arterial Hypertension Market:
Pulmonary arterial hypertension (PAH) is a rare disease, which affects the pulmonary arteries. It is nothing but a high blood pressure in the lungs. The increased blood pressure in turn, gives rise to several diseases such as heart attacks and stroke. Although there is no cure for PAH, there are medications and procedures that can slow the progression of the disease and improve the quality of life. Left untreated, it may cause heart failure, which can be fatal, and thus, it is important to start treatment as soon as possible.
Market Drivers:
Increasing prevalence of pulmonary arterial hypertension and the growing geriatric population around the world is expected to boost the growth of the global pulmonary arterial hypertension market during the forecast period. PAH is more common elderly population. For instance, as per the World Health Organization (WHO), by 2050, the world’s population of people aged 60 years and older will double (2.1 billion). This in turn expected to drive growth of the global pulmonary arterial hypertension market.
Moreover, government support for the development of orphan drugs, strong product pipeline, and increasing strategic partnerships and collaborations by key players is expected to augment growth of the global pulmonary arterial hypertension market over the forecast period.
Market Restraints:
Patent expiration of drugs and side effects associated with PAH drugs are expected to hinder growth of the global pulmonary arterial hypertension market.
Regional Insights:
Among regions, North America, Europe, and Asia Pacific are expected to witness significant growth in the global pulmonary arterial hypertension market due to the increasing incidence of PAH, growing geriatric population, government initiatives, and Strong product pipeline, and increasing awareness among people about PAH treatments.
For instance, according to American Lung Association, PAH is a rare condition, with around 500-1000 new cases being diagnosed each year in the United States. The incidence is estimated to be similar in Europe.
Competitive Section:
Major companies involved in the global pulmonary arterial hypertension market are Bayer AG, Johnson and Johnson, GlaxoSmithKline, Gilead Sciences, and Eli Lilly and Company, among others.
For instance, in February 2021, United Therapeutics launched a Remunity pump for Remodulin to treat pulmonary arterial hypertension.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Pulmonary Arterial Hypertension Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Pulmonary Arterial Hypertension Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Bayer AG
- Eli Lilly and Company
- Gilead Sciences
- GlaxoSmithKline plc
- and Johnson & Johnson
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Pulmonary Arterial Hypertension Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Prostacyclin And Prostacyclin Analogs
- Soluble Guanylate Cyclase (SGC) Stimulators
- Endothelin Receptor Antagonist (ERA)
- Phosphodiesterase 5 (PDE-5)
- Vasodilators
- Others
By Applications, the market is segmented into:
- Oral
- Intravenous
- Inhalation
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pulmonary Arterial Hypertension Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Pulmonary Arterial Hypertension Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Pulmonary Arterial Hypertension Market
1.6.1 How the Covid-19 is Affecting the Pulmonary Arterial Hypertension Market
1.6.1.1 Pulmonary Arterial Hypertension Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Pulmonary Arterial Hypertension Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Pulmonary Arterial Hypertension Market Perspective (2015-2028)
2.2 Pulmonary Arterial Hypertension Market Growth Trends by Regions
2.2.1 Pulmonary Arterial Hypertension Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Pulmonary Arterial Hypertension Market Historic Market Share by Regions (2015-2021)
2.2.3 Pulmonary Arterial Hypertension Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Pulmonary Arterial Hypertension Market Growth Strategy
2.3.6 Primary Interviews with Key Pulmonary Arterial Hypertension Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Arterial Hypertension Market Players by Market Size
3.1.1 Global Top Pulmonary Arterial Hypertension Market Players by Revenue (2015-2021)
3.1.2 Global Pulmonary Arterial Hypertension Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Pulmonary Arterial Hypertension Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pulmonary Arterial Hypertension Market Concentration Ratio
3.2.1 Global Pulmonary Arterial Hypertension Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension Market Revenue in 2019
3.3 Pulmonary Arterial Hypertension Market Key Players Head office and Area Served
3.4 Key Players Pulmonary Arterial Hypertension Market Product Solution and Service
3.5 Date of entering into Pulmonary Arterial Hypertension Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Pulmonary Arterial Hypertension Market Historic Market Size by Type (2015-2021)
4.2 Global Pulmonary Arterial Hypertension Market Forecasted Market Size by Type (2021-2028)
5 Pulmonary Arterial Hypertension Market Breakdown Data by Application (2015-2028)
5.1 Global Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
5.2 Global Pulmonary Arterial Hypertension Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Pulmonary Arterial Hypertension Market Size (2015-2021)
6.2 Pulmonary Arterial Hypertension Market Key Players in North America (2019-2021)
6.3 North America Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
6.4 North America Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
7 Europe
7.1 Europe Pulmonary Arterial Hypertension Market Size (2015-2021)
7.2 Pulmonary Arterial Hypertension Market Key Players in Europe (2019-2021)
7.3 Europe Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
7.4 Europe Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
8 China
8.1 China Pulmonary Arterial Hypertension Market Size (2015-2021)
8.2 Pulmonary Arterial Hypertension Market Key Players in China (2019-2021)
8.3 China Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
8.4 China Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
9 Japan
9.1 Japan Pulmonary Arterial Hypertension Market Size (2015-2021)
9.2 Pulmonary Arterial Hypertension Market Key Players in Japan (2019-2021)
9.3 Japan Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
9.4 Japan Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Pulmonary Arterial Hypertension Market Size (2015-2021)
10.2 Pulmonary Arterial Hypertension Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
10.4 Southeast Asia Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
11 India
11.1 India Pulmonary Arterial Hypertension Market Size (2015-2021)
11.2 Pulmonary Arterial Hypertension Market Key Players in India (2019-2021)
11.3 India Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
11.4 India Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Pulmonary Arterial Hypertension Market Size (2015-2021)
12.2 Pulmonary Arterial Hypertension Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Pulmonary Arterial Hypertension Market Size by Type (2015-2021)
12.4 Central & South America Pulmonary Arterial Hypertension Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Pulmonary Arterial Hypertension Market Introduction
13.4 Pulmonary Arterial Hypertension Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Pulmonary Arterial Hypertension Market Key Market Segments
Table 2. Key Players Covered: Ranking by Pulmonary Arterial Hypertension Market Revenue
Table 3. Ranking of Global Top Pulmonary Arterial Hypertension Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pulmonary Arterial Hypertension Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Pulmonary Arterial Hypertension Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Pulmonary Arterial Hypertension Market Players to Combat Covid-19 Impact
Table 10. Global Pulmonary Arterial Hypertension Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Pulmonary Arterial Hypertension Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Pulmonary Arterial Hypertension Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Pulmonary Arterial Hypertension Market Share by Regions (2015-2021)
Table 14. Global Pulmonary Arterial Hypertension Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Pulmonary Arterial Hypertension Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pulmonary Arterial Hypertension Market Growth Strategy
Table 20. Main Points Interviewed from Key Pulmonary Arterial Hypertension Market Players
Table 21. Global Pulmonary Arterial Hypertension Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Pulmonary Arterial Hypertension Market Share by Players (2015-2021)
Table 23. Global Top Pulmonary Arterial Hypertension Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Market as of 2019)
Table 24. Global Pulmonary Arterial Hypertension Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pulmonary Arterial Hypertension Market Product Solution and Service
Table 27. Date of entering into Pulmonary Arterial Hypertension Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 30. Global Pulmonary Arterial Hypertension Market Size Share by Type (2015-2021)
Table 31. Global Pulmonary Arterial Hypertension Market Revenue Market Share by Type (2021-2028)
Table 31. Global Pulmonary Arterial Hypertension Market Size Share by Application (2015-2021)
Table 33. Global Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 34. Global Pulmonary Arterial Hypertension Market Size Share by Application (2021-2028)
Table 35. North America Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 37. North America Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 38. North America Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 39. North America Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 40. North America Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 41. Europe Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 43. Europe Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 45. Europe Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 47. China Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 49. China Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 50. China Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 51. China Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 52. China Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 53. Japan Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 55. Japan Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 57. Japan Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 61. Southeast Asia Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 63. Southeast Asia Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 65. India Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 67. India Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 68. India Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 69. India Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 70. India Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Pulmonary Arterial Hypertension Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Pulmonary Arterial Hypertension Market Share (2019-2021)
Table 73. Central & South America Pulmonary Arterial Hypertension Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Pulmonary Arterial Hypertension Market Share by Type (2015-2021)
Table 75. Central & South America Pulmonary Arterial Hypertension Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Pulmonary Arterial Hypertension Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Pulmonary Arterial Hypertension Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Pulmonary Arterial Hypertension Market Share by Type: 2021 VS 2028
Figure 2. Global Pulmonary Arterial Hypertension Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Pulmonary Arterial Hypertension Market Report Years Considered
Figure 8. Global Pulmonary Arterial Hypertension Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Pulmonary Arterial Hypertension Market Share by Regions: 2021 VS 2028
Figure 10. Global Pulmonary Arterial Hypertension Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Pulmonary Arterial Hypertension Market Share by Players in 2019
Figure 13. Global Top Pulmonary Arterial Hypertension Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension Market Revenue in 2019
Figure 15. North America Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Pulmonary Arterial Hypertension Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
